Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday’s Mid-Day Session - First Majestic Silver (NYSE:AG), AMC Entertainment Hldgs (NYSE:AMC)

Gainers

Losers

Now Read This: Cramer Likes This Industrial Stock: A 'Well-Run' Company Doing 'A Lot Of Good Things'

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.

Gainers

Sigma Additive Solutions, Inc. (NASDAQ:SASI) shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc.
Bio-Path Holdings, Inc. (NASDAQ:BPTH) shares climbed 102% to $0.7961 after gaining more than 6% on Thursday.
Shift Technologies, Inc. (NASDAQ:SFT) gained 60% to $0.2145, after falling around 21% on Thursday.
C3is Inc. (NASDAQ:CISS) gained 32% to $0.5625.
Comtech Telecommunications Corp. (NASDAQ:CMTL) shares climbed 30.6% to $10.63 after posting better-than-expected fourth-quarter results.
Versus Systems Inc. (NASDAQ:VS) shares climbed 29.1% to $0.4246 after jumping more than 52% on Thursday.
Outlook Therapeutics, Inc. (NASDAQ:OTLK) gained 26% to $0.3448
SunOpta Inc. (NASDAQ:STKL) gained 22.5% to $3.5050 after the company announced the sale of certain frozen fruit assets to Nature's Touch for an aggregate purchase price of $141 million and issued preliminary Q3 results.
PSQ Holdings, Inc. (NYSE:PSQH) climbed 22% to $5.55. The company said preliminary third quarter revenue climbed around 300% sequentially, to an estimated $2.2 million, representing 1,600% year-over-year growth.
EHang Holdings Limited (NASDAQ:EH) jumped 21% to $20.77 after the company obtained a type certificate for the EH216-S passenger-carrying UAV system issued by the Civil Aviation Administration of China.
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) gained 18% to $1.27. SELLAS Life Sciences issued an update on Phase 3 REGAL clinical trial for Galinpepimut-S in acute myeloid leukemia.
Celularity Inc. (NASDAQ:CELU) rose 17.7% to $0.3179.
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) gained 16% to $0.3826.
Hecla Mining Company (NYSE:HL) climbed 13.7% to $4.1650 after Roth MKM upgraded the stock from Neutral to Buy and raised its price target from $4 to $4.4.
Viasat, Inc. (NASDAQ:VSAT) climbed 13.5% to $19.06.
Coeur Mining, Inc. (NYSE:CDE) gained 13.2% to $2.5399.
Groupon, Inc. (NASDAQ:GRPN) jumped 13.2% to $12.38 after Roth MKM initiated coverage on the stock with a Buy rating and $30 price target.
Synchronoss Technologies, Inc. (NASDAQ:SNCR) surged 13% to $0.5426.
Oblong, Inc. (NASDAQ:OBLG) shares gained 12.1% to $0.3286.
Blue Star Foods Corp. (NASDAQ:BSFC) shares gained 10% to $0.2201.
Staffing 360 Solutions, Inc. (NASDAQ:STAF) rose 9.2% to $0.7550.
Dollar General Corporation (NYSE:DG) climbed 8.5% to $110.50 after the company updated financial guidance for FY23 and announced Todd Vasos has been appointed CEO.
First Majestic Silver Corp. (NYSE:AG) climbed 8.5% to $5.34.
The Progressive Corporation (NYSE:PGR) gained 7.7% to $154.27 after the company reported third-quarter results.
RedHill Biopharma Ltd. (NASDAQ:RDHL) rose 6.9% to $0.3976. RedHill Biopharma recently said that its oral opaganib shows a significant increase in survival time (at 150 mg/kg twice daily dose) in a U.S. Army-funded in vivo Ebola virus study, making it the first host-directed molecule to show activity in the Ebola virus disease.
JPMorgan Chase & Co. (NYSE:JPM) gained 3.6% to $151.09 as the company reported better-than-expected earnings for its third quarter on Friday.
Wells Fargo & Company (NYSE:WFC) gained 3.2% to $41.03 following third-quarter earnings.

Losers

Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) fell 53.4% to $0.1852.
Outset Medical, Inc. (NASDAQ:OM) shares fell 47.6% to $3.55. The company announced preliminary revenue for the third quarter of $30.4 million, below the consensus estimate of $36.03 million.
MSP Recovery, Inc. (NASDAQ:LIFW) dipped 44% to $1.8109.
SMART Global Holdings, Inc. (NASDAQ:SGH) fell 40.4% to $14.04 after the company reported worse-than-expected fourth-quarter financial results and issued a weak forecast for the first quarter.
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) declined 38.3% to $18.66 after the company reported topline data from its Phase 3 INTUNE study of pitolisant for IH, noting no statistically significant difference was observed
between pitolisant and placebo on ESS.
Secoo Holding Limited (NASDAQ:SECO) fell 38% to $0.6327.
FLJ Group Limited (NASDAQ:FLJ) fell 31.9% to $0.2301.
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) declined 27.7% to $1.7999. PMV Pharmaceuticals recently announced updated Phase 1 results from its ongoing Phase 1/2 PYNNACLE trial that showed PC14586 achieved efficacy in heavily pretreated patients across multiple tumor types and was well tolerated with a favorable safety profile.
LQR House Inc. (NASDAQ:LQR) declined 26.6% to $0.1739 after the company announced the pricing of a $5.4 million public offering of 28,421,053 shares of common stock at a price of $0.19 per share.
Belden Inc. (NYSE:BDC) fell 25.7% to $70.76 after the company lowered third-quarter revenue guidance below estimates.
Scully Royalty Ltd. (NYSE:SRL) declined 25% to $4.1990.
Charles & Colvard, Ltd. (NASDAQ:CTHR) fell 23% to $0.44 following quarterly results.
Cassava Sciences, Inc. (NASDAQ:SAVA) fell 21.3% to $13.80 after a recent report by the City University of New York implicated a long-time collaborator of the company in scientific misconduct related to 20 research papers.
Edesa Biotech, Inc. (NASDAQ:EDSA) shares fell 21.1% to $3.8501 after jumping around 80% on Thursday. Edesa Biotech secured a commitment of up to C$23 million from the Government of Canada for a pivotal Phase 3 clinical study of the company's first-in-class therapeutic candidate.
Prestige Wealth Inc. (NASDAQ:PWM) fell 18.7% to $3.43.
ReShape Lifesciences Inc. (NASDAQ:RSLS) fell 17.9% to $0.2795, after surging over 25% on Thursday.
Nuwellis, Inc. (NASDAQ:NUWE) fell 17.8% to $0.8301. Nuwellis reported pricing of $2.25 million public offering of Series J convertible redeemable preferred stock and warrants.
Tian Ruixiang Holdings Ltd (NASDAQ:TIRX) fell 15.7% to $0.8850, after jumping 28% on Thursday.
BeyondSpring Inc. (NASDAQ:BYSI) shares fell 15.1% to $0.9089, after jumping 46% on Thursday.
ATRenew Inc. (NYSE:RERE) declined 13.4% to $1.8350.
Tango Therapeutics, Inc. (NASDAQ:TNGX) fell 11.5% to $6.90.
Sterling Infrastructure, Inc. (NASDAQ:STRL) fell 11.2% to $68.79.
AMC Entertainment Holdings, Inc. (NYSE:AMC) fell 9.9% to $9.91.
LogicMark, Inc. (NASDAQ:LGMK) shares fell 9.7% to $1.76 after jumping around 25% on Thursday.
Society Pass Incorporated (NASDAQ:SOPA) shares fell 9.7% to $0.3201. Society Pass shares jumped around 33% on Thursday after the company announced an equity line of up to $40 million to invest into operating subsidiaries projected to go public in 2024.
Ribbon Communications Inc. (NASDAQ:RBBN) declined 8.8% to $2.2050.
Hormel Foods Corporation (NYSE:HRL) fell 4.5% to $30.93 following the company's Thursday investor day event. Additionally, Goldman Sachs maintained a Sell rating on the stock and lowered its price target from $33 to $29.
JD.com, Inc. (NASDAQ:JD) fell 4.1% to $26.71. Macquarie downgraded JD.com from Outperform to Neutral and lowered the price target from $52 to $32, while Morgan Stanley downgraded the stock from Overweight to Equal-Weight and slashed the price target from $55 to $33.